Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Neuroendocrine 12Adrenocortical Carcinoma 9Neuroendocrine Tumors 5Small Cell Lung Carcinoma 4Thyroid Carcinoma, Anaplastic 3Peritoneal Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Sarcoma 2Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Wilms Tumor 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Pheochromocytoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroendocrine Neoplasms 1Neuroblastoma 1Mesothelioma, Malignant 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Everolimus 5Octreotide 4Leucovorin 3Capecitabine 3vatalanib 2Trastuzumab 2Temozolomide 2Oxaliplatin 2Melphalan 2Fluorouracil 2Biological Therapy 2Bevacizumab 2tipifarnib 1temsirolimus 1romidepsin 1regorafenib 1pentetreotide 1motesanib diphosphate 1folfirinox 1cixutumumab 1batifiban 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Thalidomide 1Streptozocin 1Sorafenib 1Sirolimus 1Irinotecan 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Cisplatin × Endocrine × Clear all
NCT00602082 2013-08-07

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Completed
84 enrolled
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡